Freeman Lab receives Harrington Scholar award for game-changing pulmonary fibrosis drug discovery

In collaboration with James Hagood, Ronit Freeman has received funding for new drug discovery for the treatment of pulmonary fibrosis (PF). Currently, PF has no breakthrough treatment, and has an annual mortality on par with breast cancer in the US. This new funding is poised to help reverse the lung damage caused by PF. Read more about this award here.